Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Administration of zonisamide in three cases of dementia with Lewy bodies.

Odawara T, Shiozaki K, Togo T, Hirayasu Y.

Psychiatry Clin Neurosci. 2010 Jun;64(3):327-9. doi: 10.1111/j.1440-1819.2010.02075.x.

2.

Zonisamide has beneficial effects on Parkinson's disease patients.

Murata M, Horiuchi E, Kanazawa I.

Neurosci Res. 2001 Dec;41(4):397-9.

PMID:
11755227
3.

The role of levodopa in the management of dementia with Lewy bodies.

Molloy S, McKeith IG, O'Brien JT, Burn DJ.

J Neurol Neurosurg Psychiatry. 2005 Sep;76(9):1200-3.

4.

Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.

Edwards K, Royall D, Hershey L, Lichter D, Hake A, Farlow M, Pasquier F, Johnson S.

Dement Geriatr Cogn Disord. 2007;23(6):401-5.

PMID:
17409748
5.

Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.

McKeith IG.

Neurol Clin. 2000 Nov;18(4):865-902. Review.

PMID:
11072265
6.

Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors.

Liepelt I, Maetzler W, Blaicher HP, Gasser T, Berg D.

Dement Geriatr Cogn Disord. 2007;23(6):351-67. Review.

7.

Improvement of both psychotic symptoms and Parkinsonism in a case of dementia with Lewy bodies by the combination therapy of risperidone and L-DOPA.

Kato K, Wada T, Kawakatsu S, Otani K.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Jan;26(1):201-3.

PMID:
11853113
8.

[Lewy body dementia and Parkinson disease dementia].

Meyniel C, Damier P.

Presse Med. 2007 Oct;36(10 Pt 2):1485-90. Review. French.

PMID:
17572053
9.

Pharmacotherapy of dementia with Lewy bodies.

Fernandez HH, Wu CK, Ott BR.

Expert Opin Pharmacother. 2003 Nov;4(11):2027-37. Review.

PMID:
14596656
10.

Dementia with lewy bodies: therapeutic opportunities and pitfalls.

Henriksen AL, St Dennis C, Setter SM, Tran JT.

Consult Pharm. 2006 Jul;21(7):563-75. Review.

PMID:
16934009
11.

Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.

Fernandez HH, Trieschmann ME, Burke MA, Friedman JH.

J Clin Psychiatry. 2002 Jun;63(6):513-5.

PMID:
12088163
12.

[A patient with probable dementia with Lewy bodies, who showed catatonia induced by donepezil: a case report].

Morita S, Miwa H, Kondo T.

No To Shinkei. 2004 Oct;56(10):881-4. Japanese.

PMID:
15609676
13.

Lewy body cortical involvement may not always predict dementia in Parkinson's disease.

Colosimo C, Hughes AJ, Kilford L, Lees AJ.

J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):852-6.

14.

[Treatment for dementia in parkinsonian syndromes. Efficacy of cholinesterase inhibitors].

Liepelt I, Maetzler W, Blaicher HP, Gasser T, Berg D.

Nervenarzt. 2008 Jan;79(1):36-9, 42-6. Review. German.

PMID:
17687535
15.

What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.

Minett TS, Thomas A, Wilkinson LM, Daniel SL, Sanders J, Richardson J, Littlewood E, Myint P, Newby J, McKeith IG.

Int J Geriatr Psychiatry. 2003 Nov;18(11):988-93.

PMID:
14618549
16.

Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.

Gallini A, Sommet A, Salandini AM, Veyssière P, Montastruc JL, Montastruc JL.

Mov Disord. 2007 Oct 15;22(13):1980-1. No abstract available.

PMID:
17657810
17.

Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study.

Rozzini L, Chilovi BV, Bertoletti E, Conti M, Delrio I, Trabucchi M, Padovani A.

Am J Alzheimers Dis Other Demen. 2007 Feb-Mar;22(1):42-7.

PMID:
17534001
18.
19.
20.

Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.

Harding AJ, Broe GA, Halliday GM.

Brain. 2002 Feb;125(Pt 2):391-403.

Items per page

Supplemental Content

Support Center